biopharmaceutical cmo & cro market

Global Biopharmaceutical CMO & CRO Market Research Report 2021

  • Published Date: 2021-02-26
  • Report ID: 62487
  • Pages: 132
  • Format: prudent report format

Prudent Markets Predicts that Biopharmaceutical CMO & CRO Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Biopharmaceutical CMO & CRO Market Overview:
Global Biopharmaceutical CMO & CRO Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Biopharmaceutical CMO & CRO involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.

Impact of COVID-19 on Biopharmaceutical CMO & CRO Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Biopharmaceutical CMO & CRO market in 2020.

Global Biopharmaceutical CMO & CRO Market Segmentation
By Type, Biopharmaceutical CMO & CRO market has been segmented into:
Mammalian
Non-mammalian

By Application, Biopharmaceutical CMO & CRO market has been segmented into:
Application A
Application B
Application C

Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)

Top Key Players Covered in Biopharmaceutical CMO & CRO market are:
Lonza
Boehringer Ingelheim GmbH
Rentschler Biotechnologie GmbH
Inno Biologics Sdn Bhd
JRS Pharma
BIOMEVA GmbH
ProBioGen
FUJIFILM Diosynth Biotechnologies U.S.A.
Inc.
TOYOBO CO.
LTD
Samsung BioLogics
Patheon
CMC Biologics
Binex Co.
Ltd.
AbbVie Inc.
WuXi Biologics


1. Market Overview of Biopharmaceutical CMO & CRO
1.1 Biopharmaceutical CMO & CRO Market Overview
1.1.1 Biopharmaceutical CMO & CRO Product Scope
1.1.2 Market Status and Outlook
1.2 Biopharmaceutical CMO & CRO Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Biopharmaceutical CMO & CRO Historic Market Size by Regions (2015-2020)
1.4 Biopharmaceutical CMO & CRO Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Biopharmaceutical CMO & CRO Sales Market by Type (2015-2026)
2.1 Global Biopharmaceutical CMO & CRO Historic Market Size by Type (2015-2020)
2.2 Global Biopharmaceutical CMO & CRO Forecasted Market Size by Type (2021-2026)
2.3 Mammalian
2.4 Non-mammalian
3. Covid-19 Impact Biopharmaceutical CMO & CRO Sales Market by Application (2015-2026)
3.1 Global Biopharmaceutical CMO & CRO Historic Market Size by Application (2015-2020)
3.2 Global Biopharmaceutical CMO & CRO Forecasted Market Size by Application (2021-2026)
3.3 Application A
3.4 Application B
3.5 Application C
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Biopharmaceutical CMO & CRO Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Biopharmaceutical CMO & CRO Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Biopharmaceutical CMO & CRO Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Biopharmaceutical CMO & CRO Business
5.1 Lonza
5.1.1 Lonza Company Profile
5.1.2 Lonza Biopharmaceutical CMO & CRO Product Specification
5.1.3 Lonza Biopharmaceutical CMO & CRO Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 Boehringer Ingelheim GmbH
5.2.1 Boehringer Ingelheim GmbH Company Profile
5.2.2 Boehringer Ingelheim GmbH Biopharmaceutical CMO & CRO Product Specification
5.2.3 Boehringer Ingelheim GmbH Biopharmaceutical CMO & CRO Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 Rentschler Biotechnologie GmbH
5.3.1 Rentschler Biotechnologie GmbH Company Profile
5.3.2 Rentschler Biotechnologie GmbH Biopharmaceutical CMO & CRO Product Specification
5.3.3 Rentschler Biotechnologie GmbH Biopharmaceutical CMO & CRO Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 Inno Biologics Sdn Bhd
5.4.1 Inno Biologics Sdn Bhd Company Profile
5.4.2 Inno Biologics Sdn Bhd Biopharmaceutical CMO & CRO Product Specification
5.4.3 Inno Biologics Sdn Bhd Biopharmaceutical CMO & CRO Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 JRS Pharma
5.5.1 JRS Pharma Company Profile
5.5.2 JRS Pharma Biopharmaceutical CMO & CRO Product Specification
5.5.3 JRS Pharma Biopharmaceutical CMO & CRO Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 BIOMEVA GmbH
5.6.1 BIOMEVA GmbH Company Profile
5.6.2 BIOMEVA GmbH Biopharmaceutical CMO & CRO Product Specification
5.6.3 BIOMEVA GmbH Biopharmaceutical CMO & CRO Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 ProBioGen
5.7.1 ProBioGen Company Profile
5.7.2 ProBioGen Biopharmaceutical CMO & CRO Product Specification
5.7.3 ProBioGen Biopharmaceutical CMO & CRO Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 FUJIFILM Diosynth Biotechnologies U.S.A.
5.8.1 FUJIFILM Diosynth Biotechnologies U.S.A. Company Profile
5.8.2 FUJIFILM Diosynth Biotechnologies U.S.A. Biopharmaceutical CMO & CRO Product Specification
5.8.3 FUJIFILM Diosynth Biotechnologies U.S.A. Biopharmaceutical CMO & CRO Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 Inc.
5.9.1 Inc. Company Profile
5.9.2 Inc. Biopharmaceutical CMO & CRO Product Specification
5.9.3 Inc. Biopharmaceutical CMO & CRO Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.10 TOYOBO CO.
5.10.1 TOYOBO CO. Company Profile
5.10.2 TOYOBO CO. Biopharmaceutical CMO & CRO Product Specification
5.10.3 TOYOBO CO. Biopharmaceutical CMO & CRO Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.11 LTD
5.11.1 LTD Company Profile
5.11.2 LTD Biopharmaceutical CMO & CRO Product Specification
5.11.3 LTD Biopharmaceutical CMO & CRO Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.12 Samsung BioLogics
5.12.1 Samsung BioLogics Company Profile
5.12.2 Samsung BioLogics Biopharmaceutical CMO & CRO Product Specification
5.12.3 Samsung BioLogics Biopharmaceutical CMO & CRO Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.13 Patheon
5.13.1 Patheon Company Profile
5.13.2 Patheon Biopharmaceutical CMO & CRO Product Specification
5.13.3 Patheon Biopharmaceutical CMO & CRO Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.14 CMC Biologics
5.14.1 CMC Biologics Company Profile
5.14.2 CMC Biologics Biopharmaceutical CMO & CRO Product Specification
5.14.3 CMC Biologics Biopharmaceutical CMO & CRO Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.15 Binex Co.
5.15.1 Binex Co. Company Profile
5.15.2 Binex Co. Biopharmaceutical CMO & CRO Product Specification
5.15.3 Binex Co. Biopharmaceutical CMO & CRO Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.16 Ltd.
5.16.1 Ltd. Company Profile
5.16.2 Ltd. Biopharmaceutical CMO & CRO Product Specification
5.16.3 Ltd. Biopharmaceutical CMO & CRO Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.17 AbbVie Inc.
5.17.1 AbbVie Inc. Company Profile
5.17.2 AbbVie Inc. Biopharmaceutical CMO & CRO Product Specification
5.17.3 AbbVie Inc. Biopharmaceutical CMO & CRO Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.18 WuXi Biologics
5.18.1 WuXi Biologics Company Profile
5.18.2 WuXi Biologics Biopharmaceutical CMO & CRO Product Specification
5.18.3 WuXi Biologics Biopharmaceutical CMO & CRO Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Biopharmaceutical CMO & CRO Market Size (2015-2026)
6.2 North America Biopharmaceutical CMO & CRO Key Players in North America (2015-2020)
6.3 North America Biopharmaceutical CMO & CRO Market Size by Type (2015-2020)
6.4 North America Biopharmaceutical CMO & CRO Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Biopharmaceutical CMO & CRO Market Size (2015-2026)
7.2 East Asia Biopharmaceutical CMO & CRO Key Players in North America (2015-2020)
7.3 East Asia Biopharmaceutical CMO & CRO Market Size by Type (2015-2020)
7.4 East Asia Biopharmaceutical CMO & CRO Market Size by Application (2015-2020)
8. Europe
8.1 Europe Biopharmaceutical CMO & CRO Market Size (2015-2026)
8.2 Europe Biopharmaceutical CMO & CRO Key Players in North America (2015-2020)
8.3 Europe Biopharmaceutical CMO & CRO Market Size by Type (2015-2020)
8.4 Europe Biopharmaceutical CMO & CRO Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Biopharmaceutical CMO & CRO Market Size (2015-2026)
9.2 South Asia Biopharmaceutical CMO & CRO Key Players in North America (2015-2020)
9.3 South Asia Biopharmaceutical CMO & CRO Market Size by Type (2015-2020)
9.4 South Asia Biopharmaceutical CMO & CRO Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Biopharmaceutical CMO & CRO Market Size (2015-2026)
10.2 Southeast Asia Biopharmaceutical CMO & CRO Key Players in North America (2015-2020)
10.3 Southeast Asia Biopharmaceutical CMO & CRO Market Size by Type (2015-2020)
10.4 Southeast Asia Biopharmaceutical CMO & CRO Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Biopharmaceutical CMO & CRO Market Size (2015-2026)
11.2 Middle East Biopharmaceutical CMO & CRO Key Players in North America (2015-2020)
11.3 Middle East Biopharmaceutical CMO & CRO Market Size by Type (2015-2020)
11.4 Middle East Biopharmaceutical CMO & CRO Market Size by Application (2015-2020)
12. Africa
12.1 Africa Biopharmaceutical CMO & CRO Market Size (2015-2026)
12.2 Africa Biopharmaceutical CMO & CRO Key Players in North America (2015-2020)
12.3 Africa Biopharmaceutical CMO & CRO Market Size by Type (2015-2020)
12.4 Africa Biopharmaceutical CMO & CRO Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Biopharmaceutical CMO & CRO Market Size (2015-2026)
13.2 Oceania Biopharmaceutical CMO & CRO Key Players in North America (2015-2020)
13.3 Oceania Biopharmaceutical CMO & CRO Market Size by Type (2015-2020)
13.4 Oceania Biopharmaceutical CMO & CRO Market Size by Application (2015-2020)
14. South America
14.1 South America Biopharmaceutical CMO & CRO Market Size (2015-2026)
14.2 South America Biopharmaceutical CMO & CRO Key Players in North America (2015-2020)
14.3 South America Biopharmaceutical CMO & CRO Market Size by Type (2015-2020)
14.4 South America Biopharmaceutical CMO & CRO Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Biopharmaceutical CMO & CRO Market Size (2015-2026)
15.2 Rest of the World Biopharmaceutical CMO & CRO Key Players in North America (2015-2020)
15.3 Rest of the World Biopharmaceutical CMO & CRO Market Size by Type (2015-2020)
15.4 Rest of the World Biopharmaceutical CMO & CRO Market Size by Application (2015-2020)
16 Biopharmaceutical CMO & CRO Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porters Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
CHOOSE LICENCE TYPE
prudent payment methods
Contact Us

Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071

Drop us an email at
sales@prudentmarkets.com

Why Choose Us
24 * 7 Access to Analyst :

Get your pre and post sales queries resolved by our Subject matter experts.

Customization :

We will assist you to customize the report to fit your research needs.

Assured Quality :

Our prime focus is to provide qualitative and accurate data.

Free sample report :

Feel free to order a sample report before purchase.

Security :

Your personal and confidential information is safe and secured.